SSII:NSD-SS Innovations International Inc. Common Stock (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 10.75

Change

+0.24 (+2.28)%

Market Cap

USD 2.20B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI " Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya " XR Pre-Operative Simulator, a robotic surgery platform; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa " Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

-1.35 (-1.65%)

USD 23.46B
PODD Insulet Corporation

+1.78 (+0.69%)

USD 17.22B
MASI Masimo Corporation

-3.56 (-2.14%)

USD 7.80B
BRKR Bruker Corporation

+0.29 (+0.72%)

USD 5.53B
IRTC iRhythm Technologies Inc

+4.64 (+3.54%)

USD 3.38B
PRCT Procept Biorobotics Corp

-1.21 (-2.18%)

USD 2.85B
TMDX TransMedics Group Inc

+2.23 (+2.48%)

USD 2.73B
LIVN LivaNova PLC

-0.50 (-1.36%)

USD 1.95B
QDEL Quidel Corporation

-1.43 (-4.91%)

USD 1.89B
NVCR Novocure Ltd

-0.39 (-2.15%)

USD 1.81B

ETFs Containing SSII

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 115.00% 98% N/A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.00% 98% N/A 98% N/A
Trailing 12 Months  
Capital Gain 138.89% 97% N/A 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 138.89% 97% N/A 96% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -9.77% 36% F 24% F
Dividend Return -9.77% 36% F 23% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 44.85% 61% D- 39% F
Risk Adjusted Return -21.78% 33% F 26% F
Market Capitalization 2.20B 94% A 82% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector